Source: Annual Congress 2006 - Miscellaneous respiratory infections I
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. F. Erer, E. E. Dalgic, G. Senol, S. A. Ozkan (Izmir, Turkey). Role and distribution of infectious agents in exacerbations of moderate, severe and very severe forms of chronic obstructive lung disease: a prospective trial. Eur Respir J 2006; 28: Suppl. 50, 4221

Member's Comments

No comment yet.

Related content which might interest you: Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021 Measurement properties of exacerbations of chronic pulmonary disease tool (EXACT) in a clinical trial of patients with moderate to severe COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Longitudinal changes in the nature, severity and frequency of COPD exacerbations Source: Eur Respir J 2003 Dec 01;22(6):931-936 Year: 2003 The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Prospective study of infectious bacterial etiology of acute exacerbation of chronic obstructive pulmonary disease in India Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Phenotype of patients with severe pulmonary hypertension secondary to chronic obstructive pulmonary disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Source: Eur Respir J 2002; 19: 966-975 Year: 2002 Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006 Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations Source: Eur Respir J 2003; 21: 68-73 Year: 2003 Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 The effects of oral clarithromycin on airway inflammation in moderate to severe chronic obstructive pulmonary disease (COPD) - a double blind randomised controlled trial Source: Eur Respir J 2001; 18: Suppl. 33, 338s Year: 2001 The efficacy and side-effects of varenicline in patients with mild to moderate chronic obstructive pulmonary diseases Source: Annual Congress 2010 - Passive smoking Year: 2010 Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Severity assessment in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005